Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Corbett

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|February 1, 1980
Understanding iranJ W Corbett
Science (New York, N.Y.)|June 1, 1973
Late pleistocene extinctionsJ W Corbett, B G Beddall, J Bronowski, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 15, 1992
Structure of a chiral intermediate in the synthesis of (+)-19-epiajmalicineV M Lynch, J W Corbett, S F Martin, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|February 15, 1991
Structure of a key intermediate in the synthesis of (-)-5-carboxytetrahydroalstonine and (-)-tetrahydroalstonineV M Lynch, J W Corbett, S F Martin, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptaseJ W Corbett, K J Kresge, S Pan, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitorsJ W Corbett, L A Gearhart, S S Ko, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S Pan, J A Markwalder, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitorsJ W Corbett, K Dirico, W Song, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|February 1, 1980
Understanding iranJ W Corbett
Science (New York, N.Y.)|June 1, 1973
Late pleistocene extinctionsJ W Corbett, B G Beddall, J Bronowski, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 15, 1992
Structure of a chiral intermediate in the synthesis of (+)-19-epiajmalicineV M Lynch, J W Corbett, S F Martin, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|February 15, 1991
Structure of a key intermediate in the synthesis of (-)-5-carboxytetrahydroalstonine and (-)-tetrahydroalstonineV M Lynch, J W Corbett, S F Martin, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptaseJ W Corbett, K J Kresge, S Pan, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitorsJ W Corbett, L A Gearhart, S S Ko, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S Pan, J A Markwalder, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitorsJ W Corbett, K Dirico, W Song, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Pageof 1